About Compass Therapeutics
Compass Therapeutics is a company based in Cambridge (United States) founded in 2013.. Compass Therapeutics has raised $238.46 million across 5 funding rounds from investors including BioMed Realty, TD Securities and Orbimed. The company has 35 employees as of December 31, 2024. Compass Therapeutics has completed 1 acquisition, including TRIGR Therapeutics. Compass Therapeutics offers products and services including COMPANION-002, COMPANION-003, CTX-471, and CTX-8371. Compass Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Cambridge, United States
- Employees 35 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Compass Therapeutics, Inc.
-
Annual Revenue
$850 K0as on Dec 31, 2024
-
Net Profit
$-49.38 M-16.19as on Dec 31, 2024
-
EBITDA
$-54.87 M-13.2as on Dec 31, 2024
-
Total Equity Funding
$238.46 M (USD)
in 5 rounds
-
Latest Funding Round
$60.48 M (USD), Series A
Jun 23, 2020
-
Investors
BioMed Realty
& 11 more
-
Employee Count
35
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Compass Therapeutics
Compass Therapeutics is a publicly listed company on the NASDAQ with ticker symbol CMPX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Compass Therapeutics
Compass Therapeutics offers a comprehensive portfolio of products and services, including COMPANION-002, COMPANION-003, CTX-471, and CTX-8371. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Trial for first-line treatment of biliary tract cancer using antibodies.
Trial advancing cancer therapies through immune response optimization.
Antibody therapy combined with KEYTRUDA for cancer treatment.
Product candidate targeting tumor microenvironment in oncology.
Unlock access to complete
Unlock access to complete
Funding Insights of Compass Therapeutics
Compass Therapeutics has successfully raised a total of $238.46M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $60.48 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $60.5M
-
First Round
First Round
(28 May 2015)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Series A - Compass Therapeutics | Valuation | Consonance Capital | |
| Jul, 2018 | Amount | Series A - Compass Therapeutics | Valuation | Orbimed | |
| Sep, 2016 | Amount | Series A - Compass Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Compass Therapeutics
Compass Therapeutics has secured backing from 12 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include BioMed Realty, TD Securities and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in seed & series A startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Compass Therapeutics
Compass Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include TRIGR Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecule therapeutics for cancer are developed by the company.
|
2018 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Compass Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Compass Therapeutics Comparisons
Competitors of Compass Therapeutics
Compass Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Compass Therapeutics
Frequently Asked Questions about Compass Therapeutics
When was Compass Therapeutics founded?
Compass Therapeutics was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Where is Compass Therapeutics located?
Compass Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Compass Therapeutics a funded company?
Compass Therapeutics is a funded company, having raised a total of $238.46M across 5 funding rounds to date. The company's 1st funding round was a Series A of $45.98M, raised on May 28, 2015.
How many employees does Compass Therapeutics have?
As of Dec 31, 2024, the latest employee count at Compass Therapeutics is 35.
What is the annual revenue of Compass Therapeutics?
Annual revenue of Compass Therapeutics is $850K as on Dec 31, 2024.
What does Compass Therapeutics do?
Compass Therapeutics was founded in 2013 and is headquartered in Cambridge, United States. Operations center on the discovery and development of therapeutic antibodies targeting cancer. Focus is placed on combinations of human monoclonal antibodies, multiclonal mixtures, and engineered protein constructs to address the tumor-immune synapse. The company operates within the biotechnology sector, emphasizing oncology applications.
Who are the top competitors of Compass Therapeutics?
Compass Therapeutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Compass Therapeutics offer?
Compass Therapeutics offers COMPANION-002, COMPANION-003, CTX-471, and CTX-8371.
Is Compass Therapeutics publicly traded?
Yes, Compass Therapeutics is publicly traded on NASDAQ under the ticker symbol CMPX.
How many acquisitions has Compass Therapeutics made?
Compass Therapeutics has made 1 acquisition, including TRIGR Therapeutics.
Who are Compass Therapeutics's investors?
Compass Therapeutics has 12 investors. Key investors include BioMed Realty, TD Securities, Orbimed, F-Prime Capital, and Borealis Ventures.
What is Compass Therapeutics's ticker symbol?
The ticker symbol of Compass Therapeutics is CMPX on NASDAQ.